2009 Form 990-PF - Bill & Melinda Gates Foundation

BILL & MELINDA GATES FOUNDATION 56-2618866
FORM 990PF, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR
RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR
AND
ATTACHMENT 18 (CONT'D)
RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT
800 EAST LEIGH STREET US NON-EXEMPT
RICHMOND, NC 23219
SHIELD TO ENABLE HIV-INFECTED MOTHERS TO
BREASTFEED THEIR INFANTS WITHOUT RISKING
TRANSMISSION OF THE VIRUS.
D REV DESIGN FOR OTHER 90 PERCENT NONE TO SURVEY AND MARKET-TEST ULTRA-LOW-COST
425,257.
D-REV 509(A)(1)
631 EMERSON ST
PALTO ALTO, CA 94301
MULTIMEDIA DEVICES FOR USE IN AGRICULTURAL
EXTENSION WORK
DALLAS INDEPENDENT SCHOOL DISTRICT NONE TO SUPPORT THE DESIGN AND ROLL-OUT OF DATA
1,689,495.
3700 ROSS AVENUE 170(C)(1)
DALLAS, TX 752045491
SYSTEMS TO IMPROVE TEACHING AND LEARNING AND
BUILD DISTRICT CAPACITY TO USE DATA AS A TOOL
TO IMPROVE TEACHING, LEARNING AND COLLEGE
READINESS
DANA-FARBER CANCER INSTITUTE NONE TO DEVELOP A VACCINE IMUNOGEN CAPABLE OF
686,678.
HARVARD MEDICAL SCHOOL 509(A)(1)
44 BINNEY STREET JFB-809
BOSTON, MA 02115
ELICITING BROADLY NEUTRALIZING ANTIBODIES TO
PREVENT NFECTION WITH THE HIV STRAINS MOST
COMMON IN AFRICA.
DANA-FARBER CANCER INSTITUTE NONE RUTH RUPRECHT OF THE DANA-FARBER CANCER
100,000.
HARVARD MEDICAL SCHOOL 509(A)(1)
44 BINNEY STREET JFB-809
BOSTON, MA 02115
FOR PUBLIC DISCLOSURE
63 OF 519
INSTITUTE IN THE U.S. WILL DEVELOP A NEW
VACCINE PLATFORM FOR HIV BASED ON THE
HYPOTHESIS THAT IMMUNODOMINANT REGIONS OF THE
VIRUS MAY BE IRRELEVANT TO NEUTRALIZING THE
VIRUS AND ALSO PREVENT ACCESS TO NEUTRALIZING
EPITOPES IN CONSERVED REGIONS. THE TEAM WILL
ALSO USE STRUCTURAL MIMICS OF IMPORTANT
EPITOPES IN AN EFFORT TO GENERATE A STRONG,
BROADLY NEUTRALIZING ANTIBODY RESPONSE AGAINST
THESE CONVERSED SITES.
ATTACHMENT 18